ClinicalTrials.Veeva

Menu

Longitudinal Study for the Development of Innovative Wearable Tools for Foetal Wellbeing Monitoring

B

Bloom Technologies

Status

Completed

Conditions

Foetal Wellbeing

Treatments

Device: TMSi Porti
Device: Bloomlife sensor

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

The purpose of this study is to support the development of a new generation of the Bloomlife sensor, enabling continuous monitoring of foetal wellbeing.

Data is collected in four Phases, with different experimental setups. Recordings with investigational and reference devices are performed on the subjects, at different gestational ages.

The collected data is used for developing algorithms for the extraction of parameters descriptive of foetal wellbeing.

Clinical information related to subjects' pregnancy and foetal health is also collected.

Enrollment

231 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Pregnant
  • Gestational age of at least 20 weeks
  • Singleton pregnancy
  • Willingness to participate in the study

Exclusion criteria

  • Multiple pregnancy
  • Implanted pacemaker or any other implanted electrical device
  • History of allergies to silicone-based adhesives

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

231 participants in 2 patient groups

Phase I
Experimental group
Description:
Data collections are performed with TMSi Porti system and CTG (reference)
Treatment:
Device: TMSi Porti
Phases II-III-IV
Experimental group
Description:
Data collections are performed with the Bloomlife sensor and CTG (reference)
Treatment:
Device: Bloomlife sensor

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems